Tiragolumab (anti-TIGIT)

Synonyms: RG6058, MTIG7192A

Catalog No.A2028 Purity:99.86%

Tiragolumab (anti-TIGIT) (RG6058, MTIG7192A) is a humanized IgG1/kappa monoclonal antibody that binds TIGIT to prevent its interaction with its ligand PVR (CD155).

Click to purchase the isotype control of Tiragolumab (anti-TIGIT)

Selleck's Tiragolumab (anti-TIGIT) has been cited by 4 publications

Purity & Quality Control

Batch: Purity: 99.86% Protein concentration: 5 mg/ml Endotoxin Level: <1 EU/mg

99.86

Choose Selective Immunology & Inflammation related Inhibitors

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Tiragolumab (anti-TIGIT) (RG6058, MTIG7192A) is a humanized IgG1/kappa monoclonal antibody that binds TIGIT to prevent its interaction with its ligand PVR (CD155).

References
[1] N. Patil, et al. IMMUNOTHERAPEUTIC APPROACHES\| VOLUME 16, ISSUE 3, SUPPLEMENT , S635-S636, MARCH 01, 2021.

References

[1] N. Patil, et al. IMMUNOTHERAPEUTIC APPROACHES| VOLUME 16, ISSUE 3, SUPPLEMENT , S635-S636, MARCH 01, 2021.

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1918185-84-8
Molecular Weight	149 KDa
Isotype	Human IgG1, κ
Source	CHO cells
Purification	PBS Buffer, PH 7.4
Sterility	0.2 μM filtered
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.